Learn More
Apexbio Technology LLC Fluvoxamine 54739-18-3 50mg

Supplier: Apexbio Technology LLC B120550
Fluvoxamine (CAS 54739-18-3) is an antidepressant small molecule that functions primarily by selectively inhibiting serotonin (5-HT) reuptake In vitro studies have shown its ability to inhibit 5-HT uptake in platelets and brain synaptosomes In animal models fluvoxamine administration elevates extracellular serotonin levels across various brain regions and in combination with quetiapine also elevates dopamine levels in specific areas including prefrontal cortex and thalamus Additionally fluvoxamine modulates synaptic plasticity and displays potential analgesic effects mediated via serotonin receptor subtypes (5-HT1A 5-HT2A/2C and 5-HT3) Due to this pharmacological profile fluvoxamine serves as a valuable tool in neurological and psychiatric research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.